Heartflow received nationwide UnitedHealthcare coverage for its AI CT plaque analysis software and announced plans for a $200M IPO at a $1.3B valuation.
Key Details
- 1UnitedHealthcare will provide nationwide coverage for Heartflow's CT-based plaque analysis software, effective October 1.
- 2Coverage applies to all UnitedHealthcare plans, including commercial, Medicare Advantage, and dual-eligible offerings.
- 3Heartflow aims to raise up to $212.5 million by offering 12.5 million shares at $15–$17 per share in its IPO.
- 4Company generated about $43 million in Q2 2025, up 40% year-over-year.
- 5Heartflow's platform has assessed over 400,000 patients for coronary artery disease as of March 31, 2025.
- 6The US market opportunity for Heartflow's products is estimated at $5 billion.
Why It Matters
Nationwide insurer coverage and a strong IPO position solidify Heartflow's AI solution as a standard in coronary CT interpretation. This represents a significant step in the adoption and reimbursement of radiology AI, paving the way for broader clinical and commercial implementation.
Source
Radiology Business
Related News
•Radiology Business
Nvidia Unveils Explainable AI Models Mimicking Radiologist Reasoning
Nvidia introduces Clara Reason, a suite of explainable AI models designed to emulate radiologist workflows for interpreting medical images.
•Radiology Business
AI Outperforms Radiologists in Predicting Lung Cancer Treatment Response
AI tools demonstrate higher accuracy than radiologists in predicting lung cancer treatment response from imaging studies.
•AI in Healthcare
Key Advances and Cautions in Healthcare AI for Imaging and Clinical Workflows
Healthcare AI is advancing rapidly with new tools enhancing efficiency and effectiveness, but integration challenges and bias mitigation remain crucial, especially in imaging.